Law Firm Leader Maureen Sheehy Joins CZ Biohub as General Counsel

FOR IMMEDIATE RELEASE

SAN FRANCISCO — Sept. 17, 2018 — The Chan Zuckerberg Biohub (CZ Biohub), a nonprofit medical research organization, has hired prominent litigation attorney and law firm leader Maureen Sheehy as general counsel.

“We are thrilled to have Maureen as part of our team,” said Gajus Worthington, chief operating officer of CZ Biohub. “Her unique blend of leadership, deep litigation and regulatory expertise will be a major asset to our researchers and investigators as CZ Biohub continues to rev up as a discovery engine.”

Sheehy served in a variety of leadership roles, most recently as San Francisco office managing partner, at Kilpatrick Townsend & Stockton LLP (formerly Townsend and Townsend and Crew), a global law firm specializing in intellectual property, corporate law and litigation. As firm chair, she negotiated and oversaw the 2011 merger of Townsend and Townsend and Crew with Kilpatrick Stockton and has overseen operational initiatives that include developing an innovative talent model and implementing an award-winning corporate citizenship program. Sheehy has had an active pro bono practice, aimed at meeting the needs of underserved communities.

A graduate of the University of Chicago Law School in Chicago, Illinois, Sheehy has more than 20 years of litigation experience at the state and federal level. She has litigated complex antitrust, IP, and transactional disputes, and advised clients on internal investigations as well as legal and regulatory compliance.

Sheehy serves on the board of directors and executive committee for the East Bay Community Law Center in Berkeley, California, the largest legal aid provider in Alameda County and sits on the steering committee for Equal Rights Advocates.

News

  • GEN: Virtual Cells Go Multiscale to Predict Complex Biology

    AI models inform therapeutics that can restore diseased cells to healthy states

  • Protein Modeling, Cell Imaging and Patient-Powered Science: Reflections on Biohub’s Start to the Year

    Co-founder Priscilla Chan shares reflections following Aspen Ideas: Health on the models, tools, and people driving Biohub's progress this year.

  • Surprising drug targets for psoriasis emerge from comprehensive CRISPR study of human skin cells

    Analysis of results by AI ‘novelty filter’ led researchers to formulate topical gels that, in mice, were as effective as widely used injected therapy.